The opioid epidemic has been declared a national emergency by President Donald Trump, which means federal funding can be increased and directed toward treatment programs.
Long-term treatment with opioids is associated with more adverse outcomes in patients with polyneuropathy, including depression, overdose, and opioid dependence.
There are nearly as many migraine patients receiving opioids as there are patients receiving level A abortive medications.
After a comprehensive initiative to curb opioid prescribing, researchers identified reductions in all tracked outcomes, including a 30% decrease in prescribing opioids at high doses.
The extended-release formulation of tramadol was shown to be as effective as buprenorphine and more effective than clonidine for treating symptoms of opioid withdrawal.
Rates of opioid misuse and related overdoses have soared in recent years in the United States, highlighting the importance of screening tools to identify patients at high risk for adverse events from opioid use.
The number of opioids prescribed in the US decreased between 2010 and 2015, but the overall rate remains high.
Highlights from the National Academies of Sciences, Engineering, and Medicine report titled "Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use."
Once-weekly subcutaneous buprenorphine injections block the euphoric effects of opioids and suppress opioid withdrawal in patients with opioid use disorder.
According to the CDC, despite reductions in certain parts of the country, the amount of opioids being prescribed remains high compared with levels in 1999, with variations mostly seen at the county level.
In infants with neonatal abstinence syndrome, sublingual buprenorphine reduced the duration of treatment and decreased the length of hospital stay.
Patients with low back pain who are depressed are more likely to be prescribed opioids, and to be prescribed higher doses.
Strategies are being implemented to reduce opioid overdoses and deaths in Maryland.
About 20% of U.S. bariatric surgery patients are still using prescription opioids 7 years later.
Women are routinely prescribed more opioid medications than they need after cesarean sections, creating a high risk for misuse.
Polyneuropathy may increase the likelihood of patients receiving long-term opioid therapy.
Most opioid-dependent pregnant patients understand that intravenous drug use is a major transmission modality of hepatitis C virus.
Patients with opioid addiction are comfortable with PAs and NPs initiating and maintaining their opiate replacement therapy.
Elevated rates of new persistent opioid use were found in patients undergoing both minor and major surgical procedures.
U.S. Surgeon General Dr Vivek Murthy, MD, has been removed by the Trump White House and his position filled on a temporary basis.
A prescription weight-loss drug reduced the urge to use opiates like oxycodone.
Doctors who limit the supply of opioids they prescribe to 3 days or less may help patients reduce their risk of dependence and addiction.
Only a small percentage of adolescents undergoing treatment for severe opioid use disorders are receiving medication therapy to manage their condition.
Pennsylvania has adopted a multipronged approach to address the opioid crisis.
Buprenorphine/naloxone treatment initiated in the emergency department and prolonged for 10 weeks in primary care improved treatment engagement and reduced opioid use compared with referral or brief intervention.
The article reviews the epidemiology, clinical features, outcomes, prevention strategies, risk identification and management NAS.
An 8-day detoxification process using low-dose oral naltrexone showed superior efficacy to the standard 15-day approach that uses an agonist taper leading to induction with extended-release naltrexone
Polymorphism at the level of drug receptors, transporters, or other proteins involved in drug metabolism or action may have an impact on the effect of a drug.
Pharmaceutical companies are working to develop non-opioid drugs for chronic and postoperative pain.
If we invest in providing addiction treatment that is evidence-based and fundamentally invested in the dignity of every person who needs that treatment, a lot more people are going to find themselves ready to seek it out.
Clinical Pain Advisor Articles
- Abuse-Deterrent Opioids Might Not Be the Answer to the Opioid Crisis
- Paracetamol Superior to Placebo for Osteoarthritis Knee Pain
- Fracture Risk in Children Predicted by New Bone Density Assessment
- Collaborative Care Superior to Standard Care for Opioid Use Disorder
- Gabapentinoids: Evaluating the Benefits for Chronic Low Back Pain